StockNews.com Initiates Coverage on ObsEva (NASDAQ:OBSV)

Research analysts at StockNews.com began coverage on shares of ObsEva (NASDAQ:OBSV) in a report issued on Monday. The brokerage set a “hold” rating on the stock.

ObsEva Price Performance

The firm has a market cap of $7.94 million, a P/E ratio of -0.11 and a beta of 0.68. ObsEva has a 52-week low of $0.08 and a 52-week high of $2.14.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.